Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prothrombotic States that Predispose to Stroke.

Bradley K. Hiatt1, Steven R. Lentz

  • 1*Department of Internal Medicine, The University of Iowa, C303 GH, Iowa City, IA 52242, USA. steven-lentz@uiowa.edu

Current Treatment Options in Neurology
|October 2, 2002
PubMed
Summary

Prothrombotic states increase stroke risk. Routine testing for ischemic stroke is limited, but specific hereditary and acquired conditions warrant further investigation, especially in younger patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025

Area of Science:

  • Hematology
  • Neurology
  • Genetics

Background:

  • Prothrombotic states, both hereditary and acquired, are significant risk factors for thrombosis.
  • Key hereditary conditions include factor V Leiden and protein deficiencies, while acquired states encompass cancer and antiphospholipid syndrome.

Purpose of the Study:

  • To outline appropriate laboratory testing for prothrombotic states in ischemic stroke patients.
  • To discuss current treatment strategies and the need for further research in stroke prevention for these individuals.

Main Methods:

  • Review of established hereditary and acquired prothrombotic conditions.
  • Analysis of current guidelines for laboratory testing in ischemic stroke.
  • Evaluation of treatment approaches for acute and preventative stroke care.

Related Experiment Videos

Main Results:

  • Most hereditary prothrombotic states are not primary risk factors for arterial thrombosis.
  • Routine testing for ischemic stroke should focus on CBC, lupus anticoagulant, anticardiolipin antibodies, and homocysteine.
  • Extended testing is recommended for patients under 50 or with paradoxical embolism.

Conclusions:

  • Treatment for acute ischemic stroke in patients with prothrombotic states mirrors that of the general population.
  • Chronic anticoagulation benefits require further clinical trial investigation.
  • Established preventative strategies exist for certain conditions, with ongoing research for others.